vs
Side-by-side financial comparison of PLAYSTUDIOS, Inc. (MYPS) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
PLAYSTUDIOS, Inc. is the larger business by last-quarter revenue ($55.4M vs $39.6M, roughly 1.4× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -24.7%, a 60.6% gap on every dollar of revenue. On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -18.3%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $3.6M). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -15.6%).
PLAYSTUDIOS, Inc. develops and publishes free-to-play social and casual casino games for mobile, desktop and social platforms. It operates a loyalty rewards program that lets players redeem in-game achievements for real-world benefits including travel, dining and event tickets, serving markets across North America, Europe and Asia Pacific.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
MYPS vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $39.6M |
| Net Profit | $-13.7M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -17.7% | 32.5% |
| Net Margin | -24.7% | 35.9% |
| Revenue YoY | -18.3% | -10.9% |
| Net Profit YoY | 38.9% | 117.2% |
| EPS (diluted) | $-0.12 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $39.6M | ||
| Q3 25 | $57.6M | $43.4M | ||
| Q2 25 | $59.3M | $43.4M | ||
| Q1 25 | $62.7M | $47.3M | ||
| Q4 24 | $67.8M | $44.4M | ||
| Q3 24 | $71.2M | $53.1M | ||
| Q2 24 | $72.6M | $53.1M | ||
| Q1 24 | $77.8M | $54.8M |
| Q4 25 | $-13.7M | $14.2M | ||
| Q3 25 | $-9.1M | $12.8M | ||
| Q2 25 | $-2.9M | $2.5M | ||
| Q1 25 | $-2.9M | $21.5M | ||
| Q4 24 | $-22.4M | $6.5M | ||
| Q3 24 | $-3.1M | $2.8M | ||
| Q2 24 | $-2.6M | $18.5M | ||
| Q1 24 | $-567.0K | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -17.7% | 32.5% | ||
| Q3 25 | -13.6% | 36.6% | ||
| Q2 25 | -5.9% | 33.6% | ||
| Q1 25 | -4.4% | 51.1% | ||
| Q4 24 | -33.1% | 10.6% | ||
| Q3 24 | -6.7% | 26.1% | ||
| Q2 24 | -5.5% | 51.4% | ||
| Q1 24 | -2.2% | 44.6% |
| Q4 25 | -24.7% | 35.9% | ||
| Q3 25 | -15.8% | 29.6% | ||
| Q2 25 | -5.0% | 5.7% | ||
| Q1 25 | -4.6% | 45.4% | ||
| Q4 24 | -33.1% | 14.7% | ||
| Q3 24 | -4.3% | 5.3% | ||
| Q2 24 | -3.6% | 34.8% | ||
| Q1 24 | -0.7% | 34.2% |
| Q4 25 | $-0.12 | $0.15 | ||
| Q3 25 | $-0.07 | $0.12 | ||
| Q2 25 | $-0.02 | $0.02 | ||
| Q1 25 | $-0.02 | $0.21 | ||
| Q4 24 | $-0.18 | $0.05 | ||
| Q3 24 | $-0.02 | $0.03 | ||
| Q2 24 | $-0.02 | $0.20 | ||
| Q1 24 | $0.00 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $104.9M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $227.9M | $248.3M |
| Total Assets | $290.6M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $104.9M | $164.1M | ||
| Q3 25 | $106.3M | $127.4M | ||
| Q2 25 | $112.9M | $152.7M | ||
| Q1 25 | $107.1M | $132.1M | ||
| Q4 24 | $109.2M | $125.0M | ||
| Q3 24 | $105.2M | $137.4M | ||
| Q2 24 | $106.3M | — | ||
| Q1 24 | $127.0M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $227.9M | $248.3M | ||
| Q3 25 | $238.9M | $248.0M | ||
| Q2 25 | $245.3M | $244.6M | ||
| Q1 25 | $244.1M | $226.4M | ||
| Q4 24 | $244.7M | $195.1M | ||
| Q3 24 | $265.2M | $205.0M | ||
| Q2 24 | $263.6M | $8.8M | ||
| Q1 24 | $288.4M | $9.0M |
| Q4 25 | $290.6M | $380.4M | ||
| Q3 25 | $299.2M | $321.4M | ||
| Q2 25 | $316.2M | $315.3M | ||
| Q1 25 | $313.8M | $284.6M | ||
| Q4 24 | $323.0M | $266.1M | ||
| Q3 24 | $330.6M | $296.5M | ||
| Q2 24 | $333.4M | $19.5M | ||
| Q1 24 | $357.5M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.7M | $52.0M |
| Free Cash FlowOCF − Capex | $3.6M | $51.2M |
| FCF MarginFCF / Revenue | 6.5% | 129.3% |
| Capex IntensityCapex / Revenue | 0.2% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $25.4M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.7M | $52.0M | ||
| Q3 25 | $5.7M | $-20.9M | ||
| Q2 25 | $13.6M | $-8.3M | ||
| Q1 25 | $3.3M | $1.9M | ||
| Q4 24 | $11.6M | $-7.3M | ||
| Q3 24 | $14.6M | $5.0M | ||
| Q2 24 | $14.5M | $19.2M | ||
| Q1 24 | $5.0M | $3.7M |
| Q4 25 | $3.6M | $51.2M | ||
| Q3 25 | $5.4M | $-20.9M | ||
| Q2 25 | $13.2M | $-8.6M | ||
| Q1 25 | $3.2M | $1.7M | ||
| Q4 24 | $11.5M | $-7.9M | ||
| Q3 24 | $13.9M | $4.6M | ||
| Q2 24 | $12.8M | $18.3M | ||
| Q1 24 | $3.6M | $3.0M |
| Q4 25 | 6.5% | 129.3% | ||
| Q3 25 | 9.3% | -48.3% | ||
| Q2 25 | 22.3% | -19.9% | ||
| Q1 25 | 5.1% | 3.5% | ||
| Q4 24 | 16.9% | -17.8% | ||
| Q3 24 | 19.6% | 8.7% | ||
| Q2 24 | 17.6% | 34.5% | ||
| Q1 24 | 4.6% | 5.4% |
| Q4 25 | 0.2% | 2.0% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.7% | 0.7% | ||
| Q1 25 | 0.2% | 0.5% | ||
| Q4 24 | 0.2% | 1.3% | ||
| Q3 24 | 0.9% | 0.8% | ||
| Q2 24 | 2.4% | 1.6% | ||
| Q1 24 | 1.9% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MYPS
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
